-
BrainStorm Cell Therapeutics Announces Expansion of Clinical Trials for ALS and MS
BrainStorm Cell Therapeutics announced that the production of its therapy NurOwn will be expanded to support upcoming clinical trials, namely a Phase 3 trial in amyotrophic lateral sclerosis (ALS) and a Phase 2 trial in progressive multiple sclerosis (MS). Click here to find out more.
What are your thoughts on this news?
-
1 Reply
-
If you’re wondering where the Phase 2 trial for MS will be conducted and how to volunteer to participate, so am I. I’ve tried to contact the public relations contact for BrainStorm three times (two emails and a phone call) to ask, but I’ve had no success in reaching anyone.
Stay tuned. I’ll let everyone know what, if anything, I find out about this trial.
Ed
Log in to reply.